Molecular Tumor Boards: How They Change Treatment for Ovarian Cancer

The idea of a group of specialists reviewing cancer data is not new, but how it actually helps patients with ovarian cancer has been unclear. In a recent study, researchers looked at real‑world outcomes for two types of serous ovarian cancer: the aggressive high‑grade form and the slower low‑grade v